Exosome Purification via TFF, Sucrose Cushion Centrifugation, and BE-SEC

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for exosome purification from cell culture medium face challenges in achieving high purity and scalability, making it difficult to meet the requirements for industrial-scale applications and biomedical research.

Innovation Solution

A method combining tangential flow filtration (TFF), sucrose cushion centrifugation (SCC), and bind-elute size exclusion chromatography (BE-SEC) is employed, with specific parameters such as pore size, feed flow rate, and recovery rates to achieve high purity and efficiency in exosome purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ultracentrifugation is used to pellet exosomes based on density, then exosome isolation is achieved, but the process is time-consuming and difficult to scale up

Engineering Contradiction:

Improveexosome isolationVSAvoidproduction scalability

Core Design Contradiction:

ReliabilityVSProductivity

Solution Approach 1:

The purification process is divided into multiple sequential steps: TFF for initial concentration and clarification, followed by SEC for final purification. This segmentation allows each step to be optimized independently and enables scalable production while maintaining high purity exosome isolation.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent replaces the mechanical ultracentrifugation system with a combination of TFF (tangential flow filtration) and SEC (size exclusion chromatography). This substitution eliminates the need for high-speed centrifuges, reduces processing time, and enables easier scaling to industrial production levels.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If multiple purification steps are combined to achieve high purity, then exosome purity is improved, but the process complexity increases

Engineering Contradiction:

Improveexosome purityVSAvoidprocess complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges TFF and SEC into a integrated two-step process where TFF concentrates and clarifies the sample first, then SEC performs final purification. This combination achieves high purity (removing lipoproteins, albumin, and contaminants) while keeping the overall process manageable through systematic integration of complementary techniques.

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

TFF is used as a preliminary step to concentrate and clarify the cell culture medium before SEC purification. This preliminary action removes bulk contaminants and concentrates exosomes, making the subsequent SEC step more efficient and reducing the complexity of the overall purification process.

Inventive Principle:

Principle #10Preliminary action

3Quantity of substance

If TFF with specific parameters is used for concentration, then volume reduction is achieved, but processing time must be optimized

Engineering Contradiction:

Improvesample concentrationVSAvoidprocessing time

Core Design Contradiction:

Quantity of substanceVSLoss of time

Solution Approach 1:

The patent optimizes TFF parameters including transmembrane pressure (0.5-2.0 bar), feed flow rate, and membrane pore size (100-300 kDa) to achieve efficient concentration. By carefully controlling these parameters, the process achieves significant volume reduction (10-50 fold concentration) while minimizing processing time and maintaining exosome integrity.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly improves exosome purity and recovery efficiency, ensuring the integrity and safety of the purified exosomes for various biomedical applications, as demonstrated by CD81 marker testing and DNA contaminant ratio results.

Implementation Method 1

filtering the sample containing exosomes by tangential flow filtration (TFF) to obtain a TFF-filtered sample

Methodology Applied

Scientific EffectSize exclusion: Filter (physical)

Implementation Method 2

centrifuging the TFF-filtered sample by sucrose cushion centrifugation (SCC) to obtain a SCC-centrifuged sample

Methodology Applied

Scientific EffectDensity gradient centrifugation: Density Gradient

Implementation Method 3

purifying the SCC-centrifuged sample by bind-elute size exclusion chromatography to obtain a purified exosomes

Methodology Applied

Scientific EffectSize exclusion chromatography: Chromatography

Data Source

PatentUS12025592B1Method for purifying exosomes from a cell culture medium

Publication Date: 2024.07.02 NEXCALIBUR THERAPEUTICS CORP

AI summary

A method for purifying exosomes from a cell culture medium comprising combining at least three (03) treating stages of a sample containing exosomes in the following specific order: (A) filtering the sample containing exosomes by tangential flow filtration (TFF) to obtain a TFF-filtered sample; (B) centrifuging the TFF-filtered sample by sucrose cushion centrifugation (SCC) to obtain a SCC-centrifuged sample; and (C) purifying the SCC-centrifuged sample by bind-elute size exclusion chromatography (BE-SEC) to obtain a purified exosomes. The present invention provides a comprehensive and efficient approach for purifying exosomes from a cell culture medium, facilitating using exosomes in various biomedical applications.